← Issue №4/ week of Jul 26, 2026/Endoscopy

Association between colonoscopy and colorectal cancer risk in adults aged 75 to 85 years: a nationwide population-based cohort study.

From GI Signals issue №4: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Endoscopy retrospective · n=38,010 · Jul 24, 2026 · GIE · IF 8.0

Association between colonoscopy and colorectal cancer risk in adults aged 75 to 85 years: a nationwide population-based cohort study.

New evidencecolorectal cancer screeningepidemiologyhealth servicescolonoscopy
Clinical takeawayFor adults aged 75-79, discuss colonoscopy as an option for CRC screening during shared decision-making, weighing life expectancy and comorbidities. For those aged 80-85, particularly women, emphasize individualized decisions due to uncertain benefit and potential risks. Counsel on alcohol reduction as a modifiable CRC risk factor.
What it foundColonoscopy reduced CRC incidence to 2.8% vs 3.7% in adults aged 75-79 (aHR 0.75, 95% CI 0.66-0.84), but showed no significant benefit in those aged 80-85 (aHR 0.77, 95% CI 0.57-1.03), with a potential harm signal in women ≥80 (aHR 1.32, 95% CI 0.81-2.15). Alcohol consumption was the only modifiable factor consistently associated with increased CRC risk.
ContextSupports age-stratified screening decisions over a blanket cutoff (e.g., stopping at 75), aligning with current guidelines that recommend individualized screening for ages 76-85. Highlights the need for caution in women ≥80 due to a potential harm signal.
Refinessuggested applicable standard· USMSTF 2021 (Patel et al., Gastrointest Endosc 2022;95:1-15) / USPSTF 2021 / ACS 2018

Decision at stakewhether to continue colorectal cancer screening in adults aged 75 to 85

For average-risk adults, colorectal cancer screening is routine from age 45-75 (2021 update lowered the start age from 50 to 45; USPSTF/USMSTF/ACS concordant). The specific USMSTF criterion for stopping in previously well-screened patients is: individuals up to date with screening who have negative prior screening (particularly high-quality colonoscopy) should consider stopping at age 75 OR when life expectancy is less than 10 years, not 5 years.

From our summary of this standard, unedited — the part the paper bears on. marks omitted text. Our wording, not the guideline's; read the source for its own text.

Our full summary of this standard

For average-risk adults, colorectal cancer screening is routine from age 45-75 (2021 update lowered the start age from 50 to 45; USPSTF/USMSTF/ACS concordant). For ages 76-85, the decision to start or continue is individualized, based on shared decision-making that weighs prior screening history, comorbidity, life expectancy, CRC risk, and patient preference (USPSTF Grade C). Screening is not recommended/offered at age 86 or older. The specific USMSTF criterion for stopping in previously well-screened patients is: individuals up to date with screening who have negative prior screening (particularly high-quality colonoscopy) should consider stopping at age 75 OR when life expectancy is less than 10 years, not 5 years. Individuals without adequate prior screening may be considered for screening up to age 85 depending on age and comorbidities. New alarm symptoms (iron deficiency anemia, GI bleeding, change in bowel habits, weight loss) always warrant workup regardless of age or screening status; this remains sound general practice though it is not a specific guideline citation.

USMSTF 2021 (Patel et al., Gastrointest Endosc 2022;95:1-15) / USPSTF 2021 / ACS 2018 · reviewed 2026-07-19 ↗
Kim SY … Kim HS · Gastrointestinal Endoscopy · IF 8.0 · PubMed ↗Permalink
← Read the whole of issue №4 Every paper GI Signals surfaces gets a page like this one. All issues